Skip to main content
Main navigation
About us
About us
Our work
Rationale
IDDO Team
Contact us
Our partners
Governance
Governance
IDDO Board
Data Access Committee
Data reuse
Data reuse
Contributing data
Accessing data
IDDO legal and regulatory documentation
IDDO data sharing registrations
Frequently Asked Questions
Research themes
Research themes
WWARN
COVID-19
Ebola
Visceral leishmaniasis
Medicine Quality
Antimicrobial Resistance
Schistosomiasis & STHs
Chagas Disease
Febrile illness
Scrub typhus
Trachoma
Other diseases
Research
Research
Malaria Tracking Resistance
Malaria Clinical Trials Toolkit
COVID-19 LSR Tool
VL Tool
Medicine Quality Monitoring Globe
Medicine Quality Scientific Literature Surveyor
Febrile Illness Surveyor
Publications
Tools & resources
News
User account menu
Log in
Register
Contact
Bande passante
élevée
faible
Language switcher
English
Français
Español
Toggle navigation
About us
Our work
Malaria Drug Resistance
Governance
Scientific Advisory Committee
Regional Centres
Team
Tracking resistance
Tracking resistance
ACT Partner Drug Molecular Surveyor
SP Molecular Surveyor
Artemisinin Molecular Surveyor
Working together
Working together
Collaborator network
WWARN Study Groups
Sharing and accessing data
Partner projects
Tools & Resources
Malaria Clinical Trials Toolkit
WWARN Analytical Tools
Literature Reviews
External Quality Assurance
Online Courses
Procedures
Kelch markers toolkit
Tools & resources
News
News & information
Videos
Impact
Impact case studies
Publications
Rechercher
Rechercher
Rechercher
Dihydroartemisinin-Piperaquine Dose Impact Study Group Acknowledgements
Attachments
DHAPQPdoseimpact_acknowledgements_0.pdf
pdf
144.91 KB
